Prevention of Venous Thromboembolism After Stroke

REFERENCES

• Brandstater ME, Roth EJ, Siebens HC. Venous thromboembolism in stroke: literature review and implications for clinical practice. Arch Phys Med Rehabil. 1992;73:S379—S391.
   PubMed Web of Science ®Google Scholar
• McCarthy ST, Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein throm-bosis and pulmonary emboli following acute stroke. Age Aging. 1986;15:84–88.
   PubMed Web of Science ®Google Scholar
• McCarthy ST, Turner JJ, Robertson D, Hawkey CJ. Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet. 1977;11:800–801.
   Google Scholar
• Gelmers HJ. Effects of low-dose subcutaneous heparin on the occurrence of deep vein thrombosis in patients with ischemic stroke. Ada Neurol Scand. 1980;61:313–318.
   PubMed Web of Science ®Google Scholar
• Turpie AGG, Hirsh J, Jay RM, et al. Double-blind randomised trial of ORG 10172 low-molecular weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet. 1987;1:523–526.
   PubMed Web of Science ®Google Scholar
• Prins MH, Gelsema R, Sing AK, van Heerde LR, den Ottolander GJH. Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients. Haemostasis. 1989;19:245–250.
   PubMedGoogle Scholar
• Elias A, Milandre L, Langrange G, et al. Prevention des thromboses veineuses pro-fondes des membres inferieurs par une fraction d’héparine de très bas poids moléculaire (CY222) chez des patients porteurs d’une hémiplégie secondaire a un infarctus cérébral: étude pilote randomisée (30 patients). Rev Med Interne. 1990;11:95–98.
   PubMedGoogle Scholar
• Sandset PM, Dahl MS, Stiris M, Rostad B, Scheel B, Abildgaard U. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke. Semin Thromb Hemost 1990;16:25–33.
   PubMed Web of Science ®Google Scholar
• Bounds JV, Wiebers DO, Whisnant JP, Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke. 1981;12:474–477.
   PubMed Web of Science ®Google Scholar
• Brown M, Glassenberg M. Mortality factors in patients with acute stroke. JAMA. 1973;224: 1493–1495.
   PubMed Web of Science ®Google Scholar
• Viitanen M, Winblad B, Asplund K. Autopsy verified causes of death after stroke. Ada Medica Scand. 1987;222:401–408.
   PubMed Web of Science ®Google Scholar
• Wijdicks EF, Scott JP. Pulmonary embolism associated with acute stroke. Mayo Clin Proc. 1997;72:297–300.
   PubMed Web of Science ®Google Scholar
• Cope C, Reyes TM, Skversky NJ. Phlebographic analysis of the incidence of thrombosis in hemi-plegia. Radiology. 1973;109:581–584.
   PubMed Web of Science ®Google Scholar
• Miyamoto AT, Miller LS. Pulmonary embolism in stroke: prevention by early heparinization of venous thrombosis detected by Iodine-125 fib-rinogen leg scans. Arch Phys Med Rehabil. 1980;61:584–587.
   PubMed Web of Science ®Google Scholar
• Sioson ER, Crowe WE, Dawson NV. Occult proximal deep vein thrombosis: its prevalence among patients admitted to a rehabilitation hospital. Arch Phys Med Rehabil. 1988;69: 183–185.
   PubMed Web of Science ®Google Scholar
• Pambianco G, Orchard T, Landau P. Deep vein thrombosis: prevention in stroke patients dur-ing rehabilitation. Arch Phys Med Rehabil. 1995;76:324–330.
   PubMed Web of Science ®Google Scholar
• Oczkowski WJ, Ginsberg JS, Shin A, Panju A. Venous thromboembolism in patients undergo-ing rehabilitation for stroke. Arch Phys Med Rehabil. 1992;73:712–716.
   PubMed Web of Science ®Google Scholar
• Harvey RL, Roth EJ, Yarnold PR, Durham JR, Green D. Deep vein thrombosis in stroke: the use of plasma D-dimer level as a screening test in the rehabilitation setting. Stroke. 1996;27: 1516–1520.
   PubMed Web of Science ®Google Scholar
• Bromfield EB, Reding Mi. Relative risk of deep venous thrombosis or pulmonary embolism post-stroke based on ambulatory status. I Neuro Rehabil. 1988;2:51–57.
   Google Scholar
• Rosenberg RD, Bauer KA. Does a prethrombotic state exist? If so, what is it? Am J Clin Nutr. 1992;56:787S–788S.
   PubMed Web of Science ®Google Scholar
• Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative aging study. Clin Invest. 1987;80:1527–1534.
   Google Scholar
• Sorensen JV, Jensen HP, Rahr HB, et al. Haemostatic activation in patients with head injury with and without simultaneous multiple trauma. Scand J Clin Lab Invest. 1993;53: 659–665.
   PubMed Web of Science ®Google Scholar
• Desmukh M, Bisignani M, Landau P, Orchard Ti. Deep vein thrombosis in rehabilitating stroke patients. Incidence, risk factors and prophylaxis. Am] Phys Med Rehabil. 1991;70:313–316.
   Web of Science ®Google Scholar
• Skillman JJ, Collins RE, Coe MP, et al. Prevention of deep vein thrombosis in neuro-surgical patients: a controlled, randomized tri-al of external pneumatic compression boots. Surgery. 1978;83:354–358.
   PubMed Web of Science ®Google Scholar
• Turpie AGG, Gallus AS, Beattie WS, Hirsh J. Prevention of venous thrombosis in patients with intracranial disease by intermittent pneu-matic compression of the calf. Neurology. 1977;27:435–438.
   PubMed Web of Science ®Google Scholar
• Prasad BK, Banerjee AK, Howard H. Incidence of deep vein thrombosis and the effect of pneu-matic compression of the calf in elderly hemi-plegics. Age Aging. 1982;11:42–44.
   PubMed Web of Science ®Google Scholar
• Kamran S, Downey D, Ruff R. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients. Neurology. 1998;50:1683–1688.
   PubMed Web of Science ®Google Scholar
• Green D, Akuthota V, Eiken M, et al. Prevention of thromboembolism in stroke rehabilitation patients. Top Stroke Rehabil. 1998;5(2):68–74.
   Google Scholar
• Muir KW, Watt A, Baxter G, Grosset DG, Lees KR. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. Q J Med. 2000;93:359–364.
   Google Scholar
• International Stroke Trial Collaborative Group. The international stroke trial (1ST): a random-ized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet. 1997;349: 1569–1581.
   PubMed Web of Science ®Google Scholar
• Chinese Acute Stroke Trial Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349: 1641–1649.
   PubMed Web of Science ®Google Scholar
• Antiplatelet Trialists’ Collaboration. Collabora-tive overview of randomized trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81–106.
   PubMed Web of Science ®Google Scholar
• CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329–1339.
   PubMed Web of Science ®Google Scholar
• Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European stroke preven-tion study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. Neurol Sci. 1996;143:1–13.
   Web of Science ®Google Scholar
• Antiplatelet Trialists’ Collaboration. Collabora-tive overview of randomized trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ. 1994;308:235–246.
   PubMed Web of Science ®Google Scholar
• Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet. 2000;355:1295–1302.
   PubMed Web of Science ®Google Scholar
• Gubitz G, Sandercock P, Counsel I C. Antiplatelet therapy for acute ischaemic stroke. TheCochrane Library. 1999;4: U pdateSoftware.
   Google Scholar
• Gubitz G, Counsell C, Sandercock P, Signorini D. Anticoagulants for acute ischaemic stroke. TheCochrane Library. 2002;1: U pdateSoftware.
   Google Scholar
• Turpie AGG, Gent M, Cote R, et al. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Ann Intern Med. 1992;117:353–357.
   PubMed Web of Science ®Google Scholar
• Dumas R, Woitinas F, Kutnowski M, et al. A multicentre, double-blind, randomized study to compare the safety and efficacy of once-dai-ly ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke. Age Aging. 1994;23:512–516.
   PubMed Web of Science ®Google Scholar
• Hillbom M, Erila T, Sotaniemi K, Tatlisumak T, Sarna S, Kaste M. Enoxaparin vs. heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double blind study. Ada Neurol Scand. 2002;106:84–92.
   PubMed Web of Science ®Google Scholar
• TOAST Investigators. Low molecular weight heparinoid, ORG 101 72 (danaparoid), and outcome after acute ischemic stroke: a ran-domized controlled trial. JAA4A. 1998;279: 1265–1272.
   Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for pre-vention of thromboembolism in atrial fibrilla-tion: stroke prevention atrial fibrillation II study. Lancet. 1994;343:687–691.
   PubMed Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III ran-domized clinical trial. Lancet. 1996;348: 633–638.
   PubMed Web of Science ®Google Scholar
• Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AGG. Antithrombotic therapy in patients with mechanical and prosthetic heart valves. Chest. 2001;119:220S–227S.
   PubMed Web of Science ®Google Scholar
• Lip GYH, Lowe GDO, Rumley A, Dunn FG. Increased markers of thrombogenesis in chron-ic atrial fibrillation: effects of warfarin treat-ment. Br Heart J. 1995;73:527–533.
   PubMedGoogle Scholar
• Prystowsky EN, Benson DW, Fuster V, et al. Management of patients with atrial fibrillation. A statement for the healthcare professionals from the subcommittee on electrocardiogra-phy and electrophysiology. American Heart Association. Circulation. 1996;93:1262–1277.
   PubMed Web of Science ®Google Scholar
• Koefoed BG, Petersen P. Oral anticoagulation in nonvalvular atrial fibrillation. J Intern Med. 1999;245:375–381.
   PubMed Web of Science ®Google Scholar
• Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembol ism. Chest. 2001;119:132S–175S.
   PubMed Web of Science ®Google Scholar
• Dahan R, Houlbert D, Caulin C, et al. Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial. Haemostasis. 1986;16:159–164.
   PubMedGoogle Scholar